Synonyms: TCMDC-140369
Compound class:
Synthetic organic
Comment: MMV030084 is a trisubstituted imidazole, with potent antimalarial activity against multiple stages of the Plasmodium lifecycle [1].
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. ![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
The interaction table below provides data from whole cell assays and gives the antiparasite activity of MMV030084 against a number of Plasmodium lifecycle stages. During the asexual blood stages the compound may act as an egress inhibitor, with high activity against synchronized schizonts but minimal activity against rings and trophozoites [1]. MMV030084 does not display activity against either early or late stage gametocytes (IC50 values > 40μM) but does inhibit male gamete exflagellation. |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click on species/strain names for details | Click column headers to sort | ||||||||||||||||||||||||||||||||
|
Whole organism assay data | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click on species/strain names for details | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|